Beckman Coulter Life Sciences is taking actions in the best interests of our associates, customers, and business partners as we navigate the growing threats of the 2019 Novel Coronavirus disease (COVID-19).Learn More
Extracellular Vesicles for ‘Liquid Biopsy’ Development in Cancer by Dr. Karla Williams
The Williams Lab is using nanoscale flow cytometry to identify tumor-derived extracellular vesicles and to profile their protein and glycan composition. Learn how this work has led to the development of a blood-based ‘liquid biopsy’ to risk-stratifying patients, allowing them to distinguish indolent from aggressive disease.
No Related Videos
Oops. The page you wanted could not be found, so we brought you to something similar. If you still can't find what you want, try searching our site instead.